| Literature DB >> 19879426 |
Arturo Sala1, Saverio Bettuzzi, Sabina Pucci, Olesya Chayka, Michael Dews, Andrei Thomas-Tikhonenko.
Abstract
In no other field has the function of clusterin (CLU) been more controversial than in cancer genetics. After more than 20 years of research, there is still uncertainty with regard to the role of CLU in human cancers. Some investigators believe CLU to be an oncogene, others-an inhibitor of tumorigenesis. However, owing to the recent efforts of several laboratories, the role of CLU in important cellular processes like proliferation, apoptosis, differentiation, and transformation is beginning to emerge. The "enigmatic" CLU is becoming less so. In this chapter, we will review the work of research teams interested in understanding how CLU is regulated by oncogenic signaling. We will discuss how and under what circumstances oncogenes and epigenetic factors modify CLU expression, with important consequences for mammalian tumorigenesis.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19879426 PMCID: PMC3426299 DOI: 10.1016/S0065-230X(09)05007-6
Source DB: PubMed Journal: Adv Cancer Res ISSN: 0065-230X Impact factor: 6.242